← Back to Patent Explorer
US4514386A Expired / Lapsed US ⏱️ 0.0 years remaining

Cream Preparation

Assignee: Sumitomo Chemical Co Ltd
•
Filing: 1983-12-06
•
Granted: 1985-04-30
•
Expires: 2003-12-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An antiinflammatory cream preparation which comprises an antiinflammatory substance hardly soluble in water in a base composition at a concentration of 0.05 to 1.5% by weight based on the preparation, the base composition comprising a medium chain fatty acid triglyceride of which the fatty acid has 6 to 12 carbon atoms, carboxyvinyl polymer and purified water in a weight proportion of 1-25:0.3-3:75-99, and with an adjusted pH of 4 to 10. The cream preparation is excellent in the availability of the antiinflammatory substance contained therein and advantageously is low in stimulation and high in safety.

Inventors

  • 👤 Yoshiya Yamahira
  • 👤 Katsuhiko Shima
  • 👤 Chikako Matsusaka
  • 👤 Tetsuo Noguchi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:54
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/30; A61K47/32; A61K47/06; A61K47/08; A61K47/14; A61K9/00; A61K9/0012; A61K9/0014; A61P; A61P29/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 82 words
A cream preparation which consist essentially of a pharmacologically active antiinflammatory substance which is hardly soluble in water in a base composition comprising 1 to 25 parts by weight of a medium chain fatty acid triglyceride of which the fatty acid has 6 to 12 carbon atoms, 0.3 to 3 parts by weight of a carboxypolymethylene and 75 to 99 parts by weight of purified water with an adjusted pH of 4 to 10, based on the weight of the base composition.
Claim 2
Dependent Claim 82 words
A cream preparation which consist essentially of a pharmacologically active antiinflammatory substance which is hardly soluble in water in a base composition comprising 1 to 25 parts by weight of a medium chain fatty acid triglyceride of which the fatty acid has 6 to 12 carbon atoms, 0.3 to 3 parts by weight of a carboxypolymethylene and 75 to 99 parts by weight of purified water with an adjusted pH of 4 to 10, based on the weight of the base composition.
Claim 3
Dependent Claim 13 words
The cream preparation according to claim 1, wherein the antiinflammatory substance is indomethacin.
Claim 4
Dependent Claim 13 words
The cream preparation according to claim 1, wherein the antiinflammatory substance is fluorometholone.
Claim 5
Dependent Claim 26 words
The cream preparation according to claim 1, wherein the active substance is included at a concentration of 0.05 to 1.5% by weight based on the preparation.
Claim 6
Dependent Claim 31 words
The cream preparation according to claim 1 wherein the medium chain fatty acid triglyceride is selected from the group consisting of caproic acid triglyceride, capric acid triglyceride, and caprylic-capric acid triglyceride.
Claim 7
Dependent Claim 22 words
The cream preparation according to claim 1 wherein the carboxypolymethylene is a hydrophilic polymer comprising acrylic acid as the major component thereof.
Claim 8
Dependent Claim 42 words
The cream preparation according to claim 1 wherein a dispersing aid or absorbing aid is incorporated into the base composition, said dispersing or absorbing aid being selected from the group consisting of glycerol, propylene glycol, sugar fatty acid esters and diisopropyl adipate.
Claim 9
Dependent Claim 29 words
The cream preparation according to claim 1 wherein the active antiinflammatory substance is selected from the group consisting of fluorometholone, prednisolone, dexamethasone, triamcinolone, diflorazone diacetate, indomethacin, ibuprofen and flurubiprofen.
Claim 10
Dependent Claim 32 words
The cream preparation according to claim 1 wherein the active antiinflammatory substance is present in an amount of about 0.05 to 1.15% by weight based on the weight of the cream preparation.
Claim 11
Dependent Claim 19 words
The cream preparation according to claim 1 wherein the pH is adjusted by the addition of a water-soluble amine.

References Cited (Backward Citations)

US4123433A Cited
US4139625A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-04-29 1988-10-29 1989-04-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-04-29 1992-10-29 1993-04-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-04-29 1996-10-29 1997-04-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag